• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up0.56% Nasdaq Up0.35%

    La Jolla Pharmaceutical Co. (LJPC)

    29.31 Down 0.12(0.41%) 11:33AM EDT - Nasdaq Real Time Price
    Add to Portfolio
    ProfileGet Profile for:
    La Jolla Pharmaceutical Co.
    4660 La Jolla Village Drive
    Suite 1070
    San Diego, CA 92122
    United States - Map
    Phone: 858-207-4264
    Website: http://www.lajollapharmaceutical.com

    Index Membership:N/A
    Full Time Employees:25

    Business Summary 

    La Jolla Pharmaceutical Company, a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for life-threatening diseases. The company engages in developing LJPC-501, an angiotensin II for the potential treatment of catecholamine-resistant hypotension and hepatorenal syndrome; and GCS-100, a galectin-3 inhibitor for the potential treatment of chronic kidney disease. It also develops LJPC-1010 galectin-3 inhibitor for the potential treatment of nonalcoholic steatohepatitis and other diseases characterized by tissue fibrosis; and LJPC-401, a hepcidin for the potential treatment of hemochromatosis and beta thalassemia. La Jolla Pharmaceutical Company was founded in 1989 and is headquartered in San Diego, California.

    Key Statistics

    Company Websites 
    Home Page
    Search Yahoo! for:
    More on La Jolla Pharmaceutical Co.

    Key Executives 
    Dr. George F. Tidmarsh M.D., Ph.D., 55
    Chief Exec. Officer, Pres, Sec. and Director
    Mr. Dennis M. Mulroy , 59
    Chief Financial Officer
    Ms. Jennifer A. Carver MBA ,
    VP of Operations
    Prof. Lakhmir S. Chawla M.D., 44
    Chief Medical Officer
    Mr. Chester S. Zygmont III, 35
    Sr. Director of Fin.
    Amounts are as of Dec 31, 2014 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in USD.
    View Insiders